AVEO Oncology AVEO and Astellas Pharma today
announced that new clinical data on tivozanib, an investigational agent
for the treatment of metastatic renal cell carcinoma (mRCC), will be
presented at the 2013 American Society of Clinical Oncology
Genitourinary Cancers Symposium (ASCO GU), taking place February 14-16
in Orlando, Florida.
The schedule for tivozanib poster presentations at ASCO GU is as follows:
Date & Time: Saturday, February 16, 2013; 6:45-7:55am
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in